Concorde Financial’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.07M Sell
32,705
-94
-0.3% -$17.4K 3.59% 11
2025
Q1
$6.87M Sell
32,799
-98
-0.3% -$20.5K 3.79% 8
2024
Q4
$5.85M Buy
32,897
+124
+0.4% +$22K 3.48% 10
2024
Q3
$6.47M Sell
32,773
-420
-1% -$82.9K 3.81% 7
2024
Q2
$5.69M Sell
33,193
-8,225
-20% -$1.41M 3.74% 9
2024
Q1
$7.54M Sell
41,418
-70
-0.2% -$12.7K 6.86% 3
2023
Q4
$6.43M Buy
41,488
+34,788
+519% +$5.39M 4.4% 5
2023
Q3
$999K Sell
6,700
-34,038
-84% -$5.07M 1.7% 12
2023
Q2
$5.49M Sell
40,738
-570
-1% -$76.8K 3.59% 9
2023
Q1
$6.58M Sell
41,308
-581
-1% -$92.6K 4.8% 4
2022
Q4
$5.62M Hold
41,889
3.79% 6
2022
Q3
$5.62M Sell
41,889
-81
-0.2% -$10.9K 3.79% 6
2022
Q2
$6.43M Sell
41,970
-3,585
-8% -$549K 7.18% 3
2022
Q1
$6.78M Sell
45,555
-1,282
-3% -$191K 4.17% 6
2021
Q4
$6.33M Buy
+46,837
New +$6.33M 3.98% 5